Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -19.01% is 74% above its 4-year average of -71.91%, near the high end of its 4-year range (-512.36%–7.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.35% above its 12-month average of -32.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -19.01%.
RETURN ON EQUITY (ROE)
-19.01%
RETURN ON EQUITY (ROE) AVG TTM
-32.97%
RETURN ON EQUITY (ROE) AVG 3Y
-35.56%
RETURN ON EQUITY (ROE) AVG 5Y
-71.91%
RETURN ON EQUITY (ROE) AVG 10Y
-95.43%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+42.35%
CURRENT VS 3Y AVG
+46.55%
CURRENT VS 5Y AVG
+73.57%
CURRENT VS 10Y AVG
+80.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
+47.21%
vs the sector median at left
Journey Medical Corporation
Market Cap
$184.12M
Return on Equity (ROE)
-19.01%
TTM Avg
-32.97%
3Y Avg
-35.56%
5Y Avg
-71.91%
Market Cap
$179.70M
Return on Equity (ROE)
-21.57%
TTM Avg
-470.91%
3Y Avg
-299.18%
5Y Avg
-180.76%
Market Cap
$176.96M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$192.97M
Return on Equity (ROE)
-136.83%
TTM Avg
-43.45%
3Y Avg
-452.04%
5Y Avg
-306.86%
Market Cap
$174.17M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$173.04M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$172.99M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
Market Cap
$202.05M
Return on Equity (ROE)
-47.78%
TTM Avg
-64.50%
3Y Avg
-55.96%
5Y Avg
-125.52%
Market Cap
$162.82M
Return on Equity (ROE)
-59.40%
TTM Avg
-255.06%
3Y Avg
-160.44%
5Y Avg
-112.56%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $184.12M | -19.01% | -32.97% | -35.56% | -71.91% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | -21.57% | -470.91% | -299.18% | -180.76% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | -136.83% | -43.45% | -452.04% | -306.86% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -116.42% | -18.43% | -136.68% | -137.61% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -215.26% | -150.35% | 8.65% | -35.35% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | -44.23% | -36.61% | -30.86% | -42.66% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | -47.78% | -64.50% | -55.96% | -125.52% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -59.40% | -255.06% | -160.44% | -112.56% |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
ROE
-19.0%
ROA
-6.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -19.01% |
| 2026-03-31 | -31.10% |
| 2025-12-31 | -35.89% |
| 2025-09-30 | -33.45% |
| 2025-06-30 | -45.40% |
| 2025-03-31 | -38.55% |
| 2024-12-31 | -73.11% |
| 2024-09-30 | -167.82% |
| 2024-06-30 | 7.46% |
| 2024-03-31 | -32.11% |
| 2023-12-31 | -18.93% |
| 2023-09-30 | -71.09% |
| 2023-03-31 | -512.36% |
| 2022-12-31 | -174.47% |
| 2022-09-30 | -155.58% |
| 2022-06-30 | -118.70% |
| 2022-03-31 | -110.14% |
| 2021-12-31 | -104.64% |
| 2021-03-31 | 31.62% |
| 2020-12-31 | 42.38% |
| 2019-06-30 | -337.34% |
| 2019-03-31 | -304.47% |
| 2018-09-30 | -382.09% |
| 2018-06-30 | -283.13% |
| 2018-03-31 | -260.42% |
| 2017-12-31 | -202.65% |
| 2017-09-30 | -128.13% |
| 2017-06-30 | -27.11% |
| 2017-03-31 | -29.28% |
| 2016-12-31 | -47.51% |
| 2016-09-30 | -50.72% |
| 2016-06-30 | -43.48% |
| 2016-03-31 | -58.05% |
| 2015-12-31 | -42.27% |
| 2015-09-30 | -31.67% |
